Back to Search
Start Over
[Developability assessment with case studies highlighting the decision taking].
- Source :
-
Medecine sciences : M/S [Med Sci (Paris)] 2019 Dec; Vol. 35 (12), pp. 1171-1174. Date of Electronic Publication: 2020 Jan 06. - Publication Year :
- 2019
-
Abstract
- Therapeutic antibodies generation has to be faster with less development costs. This requires combination of in silico predictions associated with cutting edge screening and characterization technologies. Here, non-exhaustive examples illustrate this simultaneity need.<br /> (© 2019 médecine/sciences – Inserm.)
- Subjects :
- Drug Industry economics
Drug Industry methods
Drug Industry standards
High-Throughput Screening Assays economics
High-Throughput Screening Assays methods
High-Throughput Screening Assays standards
Humans
Antibodies, Monoclonal chemistry
Antibodies, Monoclonal economics
Antibodies, Monoclonal isolation & purification
Antibodies, Monoclonal therapeutic use
Computer Simulation
Decision Making
Drug Design
Drug Development economics
Drug Development methods
Drug Development organization & administration
Drug Development standards
Drug Evaluation, Preclinical methods
Drug Evaluation, Preclinical standards
Subjects
Details
- Language :
- French
- ISSN :
- 1958-5381
- Volume :
- 35
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Medecine sciences : M/S
- Publication Type :
- Academic Journal
- Accession number :
- 31903933
- Full Text :
- https://doi.org/10.1051/medsci/2019232